Buteyko Method for Children With Asthma

NCT02720380 | Completed

• 1 other identifier: 562.554
• Study Type: interventional
• Target: 32
• Locations: 1 country
• Sites: 1

Brief Summary

This study has the aim to assess the effectiveness of the Buteyko method as an adjunct therapy in the treatment of children with asthma.

Conditions

Asthma; Child; Breathing Exercises

Keywords

Asthma; Physical Therapy Specialty; Breathing Exercises; Child; Clinical Trail

Outcome Measures

Primary Outcomes (1)

• Change in Quality of life (questionnaire)

  Quality of life will be assessed by the Pediatric Asthma Quality of Life Questionnaire (PAQLQ).

  Baseline and three weeks later

Secondary Outcomes (6)

• Change in pulmonary function (spirometry)

  Baseline and three weeks later

• Change in the Six-minute walk test distance

  Baseline and three weeks later

• Number of visits to the emergency room

  Through study completion, an average of three weeks

• Occurrence of absences in school

  Through study completion, an average of three weeks

• Occurrence of exacerbations

  Through study completion, an average of three weeks

Study Arms (2)

Buteyko

EXPERIMENTAL

Children in the intervention group will perform 6 sessions (twice a week) of treatment with the Buteyko Method.

Other: Buteyko

Asthma education

ACTIVE COMPARATOR

Children assigned to the control group will receive, along with their parents, educational interventions in relation to asthma.

Other: Asthma education

Interventions

Buteyko OTHER

Intervention will be held twice a week during 3 weeks.

Buteyko

Asthma education OTHER

Educational interventions in relation to asthma will be given to children assigned to the control group.

Asthma education

Eligibility Criteria

• Age: 7 Years - 12 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)

You may qualify if:

• Children from 7 up to 12 years old with asthma diagnose;
• Regular inhaled corticosteroids with no change in dose in the preceding 4 weeks;
• Children cannot present: other respiratory disease (such as cystic fibrosis, bronchiectasis, tuberculosis), retinal detachment, hypertensive crisis, congenital heart defect, pulmonary edema, history of lobectomy or lung segmentectomy, respiratory infections 15 days prior to the evaluations.

You may not qualify if:

• Children that are not able to perform some of the necessary procedures;
• Give up participating in the research and present acute symptoms of respiratory tract during the assessments.

Sponsors & Collaborators

• Universidade Federal do Rio Grande do Norte: lead

Study Sites (1)

Universidade Federal do Rio Grande do Norte (UFRN)

Natal, Rio Grande do Norte, 59078970, Brazil

Location

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal investigator

Study Record Dates

• First Submitted: March 7, 2016
• First Posted: March 25, 2016
• Study Start: July 1, 2015
• Primary Completion: May 1, 2016
• Study Completion: May 1, 2016
• Last Updated: January 24, 2017

Record last verified: 2017-01

Data Sharing

• IPD Sharing: Will not share

Locations

BR (1)